Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Immunochromatographic Test Detects Syphilis Specific Antibody

By LabMedica International staff writers
Posted on 26 Oct 2010
A testing method that uses immunochromatic test strips can recognize the immunoglobulin G antibody that is specific for Treponema pallidum.

The colloidal gold-immunochromatography assay (GICA) can be used to detect syphilis and is comparable to the fluorescent treponemal antibody–absorption assay (FTA-Abs), which is the gold standard. More...


The GICA assay is based on the established syphilis-specific recombinant proteins, TPN17 and TPN47. In a study carried out at the Xiamen Center of Clinical Laboratory, (Fujian, China), serum of 14, 967 subjects were subjected to serologic test for syphilis, among which 1,326 cases were diagnosed as syphilitic. The GICA assay was compared with various other methods including the FTA-Abs TP-IgG test from EUROIMMUN Medizinische Labordiagnostika, (Lubeck, Germany).

The test strips were prepared with an immobilized fibrous membrane, a colloidal gold-conjugated glass fiber, and an absorbent paper were grouped together on a polyvinyl chloride self-adhesive floor and then cut into strips by a slitter. The strips were kept tightly sealed. A 10-μL serum specimen was dropped at the "patient area” of the immunochromatographic test strips, and the result was observed after adding 100 μL normal saline for 20 minutes. A positive result showed two red lines on designated strip zones, representing the "patient area” and the "control area,” respectively. A negative result showed only one red line on the "control area.”

The results showed that the sensitivity, specificity, and positive predictive value were 99.38% (1279/1287), 99.96% (12 975/12 980), and 99.61% (1279/1284), respectively.

Detection on 500 interference specimens indicated that the biologic false-positive rate of the GICA test was extremely low and free from other biologic and chemical factors. The GICA is much faster to perform than the FTA-Abs test, which takes between 2.5 and 3.5 hours. The authors concluded that the GICA test is convenient, fast, and inexpensive, and it can be used both as a confirmatory test and a screening indicator, instead of FTA-Abs TP-IgG. The study was published online in October 2010, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Xiamen Center of Clinical Laboratory
EUROIMMUN



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.